Global Pain Management Drugs Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Pain Management Drugs Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Market Overview:

The latest research study on the global Pain Management Drugs market finds that the global Pain Management Drugs market reached a value of USD 46128.27 million in 2022. It’s expected that the market will achieve USD 60606.55 million by 2028, exhibiting a CAGR of 4.65% during the forecast period.

Restraints

The increasing threat of generic drugs to brand drugs, the increasing death events caused by opioid consumption and the limitations of intravenous injection of NSAIDs. The increase in the completion rate of generic drugs, the expiration of patents for blockbuster drugs and the supply of substitutes such as painkillers are some of the main factors restricting the growth of the global painkillers market. In addition, the availability of alternative therapies and the increase in drug abuse have hindered the growth of the painkillers market.

Region Overview:

Asia-Pacific had the highest growth rate of all regions.

Company Overview:

Pfizer, Inc. is one of the major players operating in the Pain Management Drugs market, holding a share of 15.77% in 2020.

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company uses innovative science and digital technologies to create transformative treatments in areas of great medical need. Novartis offers patent protected prescription medicine and generic pharmaceuticals and biosimilars.

Segmentation Overview:

Among different product types, Over-The-Counter (OTC) Drugs segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Rheumatoid Arthritis Pain segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Pain Management Drugs market covered in Chapter 3:

Savella
Imitrex
Others
Celebrex
Qutenza
Zomig
Voltaren Gel
Maxalt
Cymbalta
Lidoderm

In Chapter 4 and Chapter 14.2, on the basis of types, the Pain Management Drugs market from 2018 to 2029 is primarily split into:

Prescription-Based Drugs
Over-The-Counter (OTC) Drugs

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Pain Management Drugs market from 2018 to 2029 covers:

Post-Operative Pain
Low-Back Pain
Rheumatoid Arthritis Pain
Osteoarthritis Pain
Cancer Pain
Migraine
Neuropathic Pain
Fibromyalgia
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)